You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p16

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Sjögren Syndrome Trial (68Ga-P16-093)

Not yet recruiting
  • Primary Sjögren Syndrome
  • (no location specified)
Sep 19, 2023

Glioma Trial in Beijing (68Ga-P16-093)

Recruiting
  • Glioma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 4, 2022

Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 1, 2022

Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

Recruiting
  • Oropharyngeal Cancer
  • Squamous Cell Carcinoma of the Oropharynx
  • Surgery
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
May 30, 2023

Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),

Recruiting
  • Oropharynx Cancer
  • Radiation therapy (5 days for 7 weeks)
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 5, 2023

Prostate Cancer Trial in Beijing (68Ga-PSMA-617, 68Ga-P16-093)

Recruiting
  • Prostate Cancer
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 4, 2022

Breast Cancer Trial in Beijing (Drug: 68Ga-P16-093)

Recruiting
  • Breast Cancer
  • Drug: 68Ga-P16-093
  • Beijing, China
    Peking Union Medical College Hospital
Nov 14, 2022

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-P16-093, 18F-FDG)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 21, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 21, 2022

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

Recruiting
  • Oropharynx Cancer
  • therapeutic conventional surgery
  • +5 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 4, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

Recruiting
  • Cervix Cancer
  • +2 more
  • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
  • Randers, Central Denmark Region, Denmark
    Department of Pathology
Feb 3, 2023

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Medical Chart Review
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Mar 15, 2022

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Protein P16 Expression in Ovarian Germ Cell Tumors.

Completed
Has Results
  • Ovarian Neoplasms
  • +2 more
  • p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
  • Ki67 antibody (DAKO) for malignant cases only
  • Assiut, Egypt
    Assiut University
Aug 12, 2021

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Oropharyngeal Squamous Cell Carcinoma Trial in Philadelphia (adjuvant radiotherapy)

    Recruiting
    • Oropharyngeal Squamous Cell Carcinoma
    • adjuvant radiotherapy
    • Philadelphia, Pennsylvania
    • +2 more
    Feb 2, 2023

    Alzheimer Trial in Baltimore ([18F]P16-129)

    Completed
    • Alzheimer Disease
    • Baltimore, Maryland
      Johns Hopkins Medical Institutions
    Jul 16, 2021

    Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab

    Active, not recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • Oropharynx Squamous Cell Carcinoma
    • Nivolumab Injection
    • Radiotherapy (RT)
    • Atlanta, Georgia
    • +2 more
    Mar 24, 2022

    Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +23 more
    • Biospecimen Collection
    • +2 more
    • Los Angeles, California
    • +1 more
    Jul 7, 2022

    Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8, Clinical

    Active, not recruiting
    • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8
    • +8 more
    • Durvalumab
    • +6 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Dec 7, 2021